SULZER BIOLOG INC has a total of 23 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets medical technology, pharmaceuticals and biotechnology are BADYLAK STEPHEN F, BIOMET DEUTSCHLAND GMBH and BONALIVE BIOMATERIALS OY.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | United States | 5 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Foods and drinks | |
#6 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Therapeutic chemical compounds | |
#3 | Implantable devices | |
#4 | Medical preparations | |
#5 | Unspecified technologies | |
#6 | Diagnosis and surgery | |
#7 | Peptides | |
#8 | Microorganisms | |
#9 | Enzymes | |
#10 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Benedict James J | 8 |
#2 | Atkinson Brent | 7 |
#3 | Ranieri John Paul | 6 |
#4 | Ranieri John P | 4 |
#5 | Facchiano Antonio | 4 |
#6 | Akella Rama | 4 |
#7 | Colognesi Maurizio Capogrossi | 4 |
#8 | Scoccianti Marco | 4 |
#9 | Anderson Diane Lee | 4 |
#10 | Lewis Michael | 2 |
Publication | Filing date | Title |
---|---|---|
WO0247713A2 | Composition containing a mixture of growth factor for the treatment of renal injury | |
WO0176654A1 | Methods and compositions for treating intervertebral disc degeneration | |
US6492327B2 | Isolation of purified TGF- β1 and TGF -β2 from bone tissue | |
EP1095615A1 | Device and method for detecting the condition of an articulation | |
US6511958B1 | Compositions for regeneration and repair of cartilage lesions | |
WO0048550A2 | Device and method for regeneration and repair of cartilage lesions | |
US6328762B1 | Prosthetic grafts | |
US6211157B1 | Protein mixtures to induce therapeutic angiogenesis | |
EP1019027A1 | Implantable collagen-containing putty material |